July 24, 2014 12:31 AM ET

Pharmaceuticals

Company Overview of Marinus Pharmaceuticals, Inc.

Executive Profile

Christopher Michael Cashman

Executive Chairman, Chief Executive Officer and President, Marinus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 6 different industries.

See Board Relationships
57$513,575
As of Fiscal Year 2013

Background

Mr. Christopher Michael Cashman, also known as Chris, has been Executive Chairman of Marinus Pharmaceuticals, Inc. since September 2011 and has been its Chief Executive Officer and President since October 2012. Mr. Cashman co-founded Protez Pharmaceuticals Inc. in 2003 and served as its Chief Executive Officer and President. He has over 30 years of experience in pharmaceutical business operations and commercial development. Mr. Cashman served as the Chief Executive Officer ...

Corporate Headquarters

142 Temple Street
New Haven, Connecticut 06510

United States

Phone: 203-315-0566
Fax: 203-315-0565

Board Members Memberships

Executive Chairman
Co-Founder, Prior Chief Executive Officer, President and Director
Director
Director
2010-Present
Director
2010-Present
Director
2011-Present
Executive Chairman, Chief Executive Officer and President

Education

BS
University of Minnesota
MS
Purdue University

Other Affiliations

Annual Compensation

Salary$260,000
Bonus$110,880
Total Annual Compensation$370,880

Stocks Options

Restricted Stock Awards$142,695
Exercisable Options$887,368
Unexercisable Options$1,218,719
Total Number of Options$2,106,087

Total Compensation

Total Annual Cash Compensation$370,880
Total Short Term Compensation$370,880
Other Long Term Compensation$142,695
Total Calculated Compensation$513,575
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Marinus Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.